Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2000
11/22/2000EP1053025A2 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
11/22/2000EP1053014A1 BIOLOGICALLY ACTIVE HEMAGGLUTININ FROM TYPE A $i(CLOSTRIDIUM BOTULINUM) AND METHODS OF USE
11/22/2000EP1052973A1 Transmucosal formulations of levosimendan
11/22/2000EP0736012B1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
11/22/2000EP0726267B1 Quinazoline derivatives
11/22/2000EP0705255B1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes
11/22/2000EP0669936B1 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
11/22/2000EP0663823B1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
11/22/2000CN1274362A Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline
11/22/2000CN1274344A Novel vitamin D analogues
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274281A Compsns. for treating and preventing arterial thrombosis and use of factor Xa inhibitor on its own and/or combined with platelet antiaggegating agent
11/22/2000CN1273967A Novel substituted dimeric compounds, its preparing process and medicinal compsns. containing same
11/22/2000CN1273827A Disinfecting liquid for treating tinea and pile
11/22/2000CN1273822A Oral liquid of L-arginine for treating cardiovascular and cerebrovascular diseases and its preparing process
11/22/2000CN1058710C Benzamide derivatives, process for prepn. thereof and pharmaceutical compsn. comprising same
11/22/2000CN1058705C Substituted benzene sulfone urea, benzensulfonyl thiourea its prepn., its application as medicine or diagnostic medicine and drugs containing it
11/22/2000CN1058634C Use of plant mentha spicata for preparing pile-treating medicine
11/22/2000CN1058617C Cockscomb beverage
11/22/2000CN1058615C Compound preparation of notoginseng
11/21/2000US6150557 Compounds
11/21/2000US6150526 Piperidine derivative having renin inhibiting activity
11/21/2000US6150502 Polypeptides expressed in skin cells
11/21/2000US6150417 Administering to warm blooded animals compounds such as n-tert-butyl-5-((2-(2-methoxyphenoxy)ethyl)amino)pentanamide for inducing antiemetic activity; treating anxiety, depression, and sleep disorders
11/21/2000US6150413 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders, as well as mammalian skin and hair conditions; 4-(4-(biphenyl-2-yl)but-3-en-1-ynyl)benzoic acid, for example
11/21/2000US6150412 Such as 4-(5-hydroxy-4-methoxy-2-nitrophenyl)butanoic acid; administering to inhibit catechol-o-methyl transferase; treating parkinson's disease or hypertension
11/21/2000US6150407 In a tissue or organ by contacting with a compound of given formula such as methyl-3,5-diiodo-4-(4'-methoxyphenoxy)benzoate; reducing the level of tumor necrosis factor alpha
11/21/2000US6150390 Accelerates bone formation; osteoporosis; (ltb-4(leukotriene-b-4; 5,12-dihydroxyeicosatetra-6,8,10,14-enoic acid) receptor antagonist
11/21/2000US6150388 Indole derivatives as 5-HT1 agonists
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150377 Farnesyl protein transferase inhibitors; anticarcinogenic,-tumor and -proliferative agents; also psoriasis, benign prostatic hypertrophy or restinosis; infections facilitated by farnesyl protein transferase, e.g., malaria or hepatitus delta
11/21/2000US6150373 Bicyclic nitrogen heterocycles
11/21/2000US6150362 Administering 1,3,5-substituted triazine compounds to the patient suffering from angiogenic diseases
11/21/2000US6150359 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
11/21/2000US6150356 Potassium channel inhibitors and method
11/21/2000US6150348 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
11/21/2000US6150342 Heparin derivatives for treatment of angina pectoris
11/21/2000US6150325 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150101 Methods of identifying a composition that alters connective tissue growth factor expression
11/21/2000US6150091 Direct molecular diagnosis of Friedreich ataxia
11/21/2000US6149936 DNA expression vectors for the use in the gene therapeutic treatment of vascular disorders
11/21/2000CA2031150C Sustained-release drug dosage units
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068377A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000WO2000068254A1 Spray drying of thrombin inhibitors
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000WO2000068241A1 Processes for the synthesis of oligomers using phusphoramidite compositions
11/16/2000WO2000068226A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds
11/16/2000WO2000068224A1 Substituted benzolactam compounds
11/16/2000WO2000068223A1 Ureas and their use as cell adhesion modulators
11/16/2000WO2000068213A1 Substituted bicyclic compounds
11/16/2000WO2000068208A1 Pyrimidinones derivatives for the treatment of atherosclerosis
11/16/2000WO2000068206A1 Heterocyclically substituted benzimidazoles, the production and application thereof
11/16/2000WO2000068198A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067801A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/16/2000WO2000067796A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/16/2000WO2000067770A1 Treatment of acute myocardial infarction with a substance related to the growth hormone axis
11/16/2000WO2000067764A2 Improved method for treating mammals with modified mammalian blood
11/16/2000WO2000067753A1 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067745A1 Cardioprotective composition and uses thereof
11/16/2000WO2000067744A1 Neuroprotective composition and uses thereof
11/16/2000WO2000067734A2 Use of phthalazine derivatives
11/16/2000WO2000067731A2 Medicinal substance utilization for preventing nitrate tolerance
11/16/2000WO2000048996A3 β-ALANINE DERIVATIVES
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000041669A3 Benzimidazole vascular damaging agents
11/16/2000WO2000041469A3 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037059A3 Compositions and methods to inactivate n-type calcium channels
11/16/2000WO2000037025A3 Antibodies to truncated vegf-d and uses thereof
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000034331A3 Analogues of glp-1
11/16/2000WO2000033825A3 Compositions and methods for amelioration of human female sexual dysfunction
11/16/2000WO2000032174A3 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide
11/16/2000WO2000029015A3 INFLUENCING OF ANGIGENESIS USING CD66a
11/16/2000WO2000027377A3 Phosphinate peptide analogs for the treatment of fibrotic disorders
11/16/2000WO2000026224A3 Novel macrolide antibiotics
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000WO2000001713A3 Diacylglycerol acyl transferase proteins
11/16/2000DE19921567A1 Verwendung von Phthalazine-Derivaten Use of derivatives phthalazines
11/16/2000DE19921346A1 Sprühtrocknung von Thrombininhibitoren Spray drying of thrombin inhibitors
11/16/2000DE19920775A1 Arzneistoffverwendung zur Vermeidung von Nitrattoleranz Drug use in the prevention of nitrate tolerance
11/16/2000DE19920247A1 Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung Medicaments with an amount of compounds having a nitrogen-oxygen heterocycle as active ingredient and their use
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373443A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000CA2373079A1 Substituted benzolactam compounds
11/16/2000CA2373068A1 Spray drying of thrombin inhibitors
11/16/2000CA2373010A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372704A1 Use of phthalazine derivatives
11/16/2000CA2372515A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000CA2369323A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
1 ... 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 ... 1595